FMR LLC - CITIUS PHARMACEUTICALS INC ownership

CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 73 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of CITIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,731
-83.1%
2,530
-70.3%
0.00%
Q2 2023$10,237
+1192.6%
8,531
+1162.0%
0.00%
Q1 2023$792
-28.0%
676
-51.4%
0.00%
Q4 2022$1,1001,392
+559.7%
0.00%
Q3 2022$0
-100.0%
211
-86.6%
0.00%
Q2 2022$1,0000.0%1,572
+220.2%
0.00%
Q1 2022$1,000491
+49000.0%
0.00%
Q4 2021$01
-66.7%
0.00%
Q2 2021$030.00%
Other shareholders
CITIUS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Inspire Advisors, LLC 135,508$472,0000.15%
Wealth Advisory Solutions, LLC 156,850$546,0000.13%
Horst & Graben Wealth Management LLC 75,722$264,0000.07%
Miller Investment Management, LP 50,000$174,0000.03%
GSA CAPITAL PARTNERS LLP 44,655$155,0000.02%
Triton Wealth Management, PLLC 13,100$24,0000.01%
Renaissance Technologies 1,898,351$6,606,0000.01%
B. Riley Wealth Management, Inc. 19,000$66,0000.01%
Virtu Financial LLC 19,713$69,0000.01%
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC 47,265$164,0000.01%
View complete list of CITIUS PHARMACEUTICALS INC shareholders